Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2022-01-11 00:00:00 ET · period of report 2022-01-07 · accession 0001179110-22-000397 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-11 | 2022-01-07 | PTCT | Klein Matthew B. | COO | A - Grant | $0.00 | +41.0K | 57.5K | +249% | $0 |
| D | 2022-01-11 | 2022-01-07 | PTCT | Klein Matthew B. | COO | S - Sale | $38.53 | -775 | 16.5K | -4% | -$29.9K |
| DM | 2022-01-11 | 2022-01-07 | PTCT | Klein Matthew B. | COO | A - Grant | $0.00 | +102.5K | 50.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-07 | A | A | 21,000 | $0.00 | 37,461 | D | — | — | (F3) Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023. |
| 2 | Common | Common Stock | 2022-01-07 | S | D | 775 | $38.53 | 16,461 | D | — | — | (F1) Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,250 RSUs from a January 6, 2021 grant of 9,000 RSUs. (F2) Includes 203 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2021 and 224 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2021. |
| 3 | Common | Common Stock | 2022-01-07 | A | A | 20,000 | $0.00 | 57,461 | D | — | — | (F4) Restricted stock units granted on January 7, 2022 that vest in two equal installments over two years, commencing on January 7, 2023. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-01-07 | A | A | 52,500 | $0.00 | 52,500 | D | $38.10 · — to 2032-01-06 | 52,500 Common Stock | (F5) This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-01-07 | A | A | 50,000 | $0.00 | 50,000 | D | $38.10 · — to 2032-01-06 | 50,000 Common Stock | (F6) This option was granted on January 7, 2022 and vests in two equal installments over two years, commencing on January 7, 2023. |